Serum Insulin-Like Growth Factor-I and Tumor Size in Patients with Metastatic Liver Cancer

Author(s):
Mohsen MasoodiMohsen Masoodi1,*, Rahim AghazadehRahim Aghazadeh2, Mohammad Hossein SomiMohammad Hossein Somi3, Ahmad ShavakhiAhmad Shavakhi4, Abbas Arjmand ShabestariAbbas Arjmand Shabestari2, Mohammad Reza ZaliMohammad Reza Zali2
1Department of Internal Medicine, Hormozgan University of Medical Sciences, [email protected], Hormozgan, IR.Iran
2Research Center for Gastroenterology & Liver Diseases (RCGLD), Shaheed Beheshti University of Medical Sciences, Tehran, IR.Iran
3Tabriz Liver and Gastrointestinal Diseases Research Center (LGDRC), Tabriz University of Medical Sciences, Azarbayejan-e-Sharghi, IR.Iran
4Isfahan University of Medical Sciences, Isfahan, IR.Iran

Hepatitis Monthly:Vol. 8, issue 3; 179-183
Published online:Sep 30, 2008
Article type:Research Article
Received:Nov 20, 2007
Accepted:Aug 26, 2008
How to Cite:Masoodi M, Aghazadeh R, Somi M, Shavakhi A, Shabestari A, et al. Serum Insulin-Like Growth Factor-I and Tumor Size in Patients with Metastatic Liver Cancer. Hepat Mon. 2008;8(3):. doi:

Abstract

Full Text

Full text is available in PDF
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles